English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  53348920    線上人數 :  607
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hwei fang tien"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 231-240 / 337 (共34頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2015 TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Liu M.-C.; Chiang Y.-C.; Tseng M.-H.; Lin L.-I.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN
中國醫藥大學 2014-06 Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study (Chiun Hsu);(Hsiao-Hui Tsou);(Shyh-Jer Lin);(Ming-Chung Wang);(Ming Yao);(Wen-Li Hwang);(Woei-Yau Kao);邱昌芳(Chang-Fang Chiu);(Sheng-Fung Lin);(Johnson Lin);(Cheng-Shyong Chang);(Hwei-Fang Tien);(Tsang-Wu Liu);(Pei-Jer Chen)*;(Ann-Lii Cheng)
臺大學術典藏 2014 SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution Huang, Shang-Yi; Huang, Shang-Yi; Hsu, Szu-Chun; Hsu, Szu-Chun; Ko, Bor-Sheng; Ko, Bor-Sheng; Ko, Bor-Sheng; Tsay, Woei; Tsay, Woei; Tsay, Woei; Chen, Yao-Chang; Chen, Yao-Chang; Tien, Hwei-Fang; Tien, Hwei-Fang; Tien, Hwei-Fang; Huang, Shang-Yi; Lin, Chien-Chin;Hou, Hsin-An;Chou, Wen-Chien;Kuo, Yuan-Yeh;Wu, Shang-Ju;Liu, Chieh-Yu;Chen, Chien-Yuan;Tseng, Mei-Hsuan;Huang, Chi-Fei;Lee, Fen-Yu;Liu, Ming-Chih;Liu, Chia-Wen;Tang, Jih-Luh;Yao, Ming;Huang, Shang-Yi;Hsu, Szu-Chun;Ko, Bor-Sheng;Tsay, Woei;Chen, Yao-Chang;Tien, Hwei-Fang; Lin, C.-C. and Hou, H.-A. and Chou, W.-C. and Kuo, Y.-Y. and Wu, S.-J. and Liu, C.-Y. and Chen, C.-Y. and Tseng, M.-H. and Huang, C.-F. and Lee, F.-Y. and Liu, M.-C. and Liu, C.-W. and Tang, J.-L. and Yao, M. and Huang, S.-Y. and Hsu, S.-C. and Ko, B.-S. and Tsay, W. and Chen, Y.-C. and Tien, H.-F.; 林建嶔;林吉崇;蔡偉;李玢玉;姚明;陳建源;柯博升;徐思淳;田蕙芬;劉敏枝;陳宜君;郭遠燁;黃聖懿;吳尚儒;唐季祿;周文堅;侯信安; Jhong, Ya-Syun; 林建嶔;林吉崇;蔡偉;李玢玉;姚明;陳建源;柯博升;徐思淳;田蕙芬;劉敏枝;陳宜君;郭遠燁;黃聖懿;吳尚儒;唐季祿;周文堅;侯信安; HWEI-FANG TIEN; Lin, Chien-Chin; Lin, Chien-Chin; Lin, Chien-Chin; Hou, Hsin-An; Hou, Hsin-An; WEN-CHIEN CHOU; Hou, Hsin-An; Jhong, Ya-Syun; Chou, Wen-Chien; Chou, Wen-Chien; Chou, Wen-Chien; HSIN-AN HOU; Kuo, Yuan-Yeh; YUAN-YEH KUO; Kuo, Yuan-Yeh; Wu, Shang-Ju; BOR-SHENG KO; Wu, Shang-Ju; Wu, Shang-Ju; JIH-LUH TANG; Liu, Chieh-Yu; Liu, Chieh-Yu; Chen, Chien-Yuan; Chen, Chien-Yuan; Chen, Chien-Yuan; CHIEN-CHIN LIN; Tseng, Mei-Hsuan; SHANG-YI HUANG; Tseng, Mei-Hsuan; MING YAO; Huang, Chi-Fei; Huang, Chi-Fei; Lee, Fen-Yu; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Ming-Chih; Liu, Chia-Wen; Liu, Chia-Wen; Liu, Chia-Wen; Tang, Jih-Luh; Tang, Jih-Luh; Tang, Jih-Luh; Yao, Ming; Yao, Ming; Yao, Min; 鐘雅薰; Lin, Chien-Chin;Hou, Hsin-An;Chou, Wen-Chien;Kuo, Yuan-Yeh;Wu, Shang-Ju;Liu, Chieh-Yu;Chen, Chien-Yuan;Tseng, Mei-Hsuan;Huang, Chi-Fei;Lee, Fen-Yu;Liu, Ming-Chih;Liu, Chia-Wen;Tang, Jih-Luh;Yao, Ming;Huang, Shang-Yi;Hsu, Szu-Chun;Ko, Bor-Sheng;Tsay, Woei;Chen, Yao-Chang;Tien, Hwei-Fang
臺大學術典藏 2014 Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression HWEI-FANG TIEN; Chen Y.-C.; Wu S.-J.; Tsay W.; Huang S.-Y.; Ko B.-S.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.
臺大學術典藏 2014 Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; Hsiao M.; HWEI-FANG TIEN
臺大學術典藏 2014 MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia Chen C.-Y.; Hou H.-A.; Lin T.-C.; Fang W.-H.; Ko Y.-C.; HWEI-FANG TIEN; Lin L.-I.
臺大學術典藏 2014 Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma HWEI-FANG TIEN; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Lu H.-Y.; Chen Y.-C.; Wu S.-J.; Tang J.-L.; Lin H.-H.; Yao M.; Huang S.-Y.; Lin C.-W.
臺大學術典藏 2014 The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression Lee F.-Y.; Tseng M.-H.; Huang C.-F.; Chen P.-H.; Li L.-Y.; Chen Y.-K.; Hou H.-A.; Kuo Y.-Y.; HWEI-FANG TIEN; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; Tang J.-L.; Yao M.
臺大學術典藏 2014 Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Wang M.-C.; Lin S.-J.; Tsou H.-H.; Hsu C.; Cheng A.-L.; Liu T.-W.; Chen P.-J.; HWEI-FANG TIEN; Chang C.-S.; Lin J.; Lin S.-F.; Chiu C.-F.; Kao W.-Y.; Yao M.; Hwang W.-L.
臺大學術典藏 2014 SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution Tseng M.-H.; Chen C.-Y.; Liu C.-Y.; Kuo Y.-Y.; Wu S.-J.; Chou W.-C.; Hou H.-A.; Lin C.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN

顯示項目 231-240 / 337 (共34頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目